Literature DB >> 26502132

The Roles of Providers and Patients in the Overuse of Prostate-Specific Antigen Screening in the United States.

Fangjian Guo, Di He.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26502132      PMCID： PMC4898184          DOI： 10.7326/L15-5150

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  Reducing PSA-Based Prostate Cancer Screening in Men Aged 75 Years and Older with the Use of Highly Specific Computerized Clinical Decision Support.

Authors:  Jeremy B Shelton; Lee Ochotorena; Carol Bennett; Paul Shekelle; Lorna Kwan; Ted Skolarus; Caroline Goldzweig
Journal:  J Gen Intern Med       Date:  2015-03-05       Impact factor: 5.128

2.  Prostate-cancer mortality at 11 years of follow-up.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Alvaro Páez; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Sigrid Carlsson; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Paula M Kujala; Bert G Blijenberg; Ulf-Hakan Stenman; Andreas Huber; Kimmo Taari; Matti Hakama; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2012-03-15       Impact factor: 91.245

3.  Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Claudine Isaacs; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Lawrence R Ragard; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Ann W Hsing; Grant Izmirlian; Paul F Pinsky; Barnett S Kramer; Anthony B Miller; John K Gohagan; Philip C Prorok
Journal:  J Natl Cancer Inst       Date:  2012-01-06       Impact factor: 13.506

Review 4.  Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence.

Authors:  Julia H Hayes; Michael J Barry
Journal:  JAMA       Date:  2014-03-19       Impact factor: 56.272

5.  Doctors' approaches to PSA testing and overdiagnosis in primary healthcare: a qualitative study.

Authors:  Kristen Pickles; Stacy M Carter; Lucie Rychetnik
Journal:  BMJ Open       Date:  2015-03-17       Impact factor: 2.692
  5 in total
  3 in total

1.  Communicating About Stopping Cancer Screening: Comparing Clinicians' and Older Adults' Perspectives.

Authors:  Nancy L Schoenborn; Cynthia M Boyd; Sei J Lee; Danelle Cayea; Craig E Pollack
Journal:  Gerontologist       Date:  2019-05-17

2.  Are We Choosing Wisely? Older Adults' Cancer Screening Intentions and Recalled Discussions with Physicians About Stopping.

Authors:  Ashwin A Kotwal; Louise C Walter; Sei J Lee; William Dale
Journal:  J Gen Intern Med       Date:  2019-05-30       Impact factor: 5.128

3.  Discontinuing Cancer Screening for Older Adults: a Comparison of Clinician Decision-Making for Breast, Colorectal, and Prostate Cancer Screenings.

Authors:  Justine P Enns; Craig E Pollack; Cynthia M Boyd; Jacqueline Massare; Nancy L Schoenborn
Journal:  J Gen Intern Med       Date:  2021-09-20       Impact factor: 6.473
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.